Q&A with Dr. Stefan Prokop – Alzheimer’s: From the Amyloid Hypothesis to the Cellular Phase and Beyond

Stefan Prokop, MD, is a Neuropathologist and Research Fellow at the University of Pennsylvania School of Medicine. His work is focused on Alzheimer’s Disease (AD) with a specific interest in the role of the immune system in AD pathogenesis and...

The Chronic(als) of Autoimmunity

Political climate aside, life in Britain in the 1930’s and 1940’s was harsh and infectious disease (particularly tuberculosis) was one of the most urgent health problems; such infections favored the overcrowded, unsanitary environments prevalent in many of Britain’s cities at...

/ September 25, 2018

nCounter® PlexSet™ Reagents Let You Work Smarter, Not Harder

There are several options available to researchers looking to quantify and analyze gene expression. Most of those are time-consuming and highly technical processes that require extensive replicates and quality controls. Even then, results can vary between users in the same...

Researcher Profiles: How NanoString® Neuroscience Grant Program Winners are Utilizing nCounter® Technology

Earlier this year, five neuro grant program applicants were awarded nCounter® Neuropathology or Neuroinflammation Panels to profile 24 samples. Applications spanned a wide range of disease specific applications with the winning projects focused on Alzheimer’s Disease (AD), Parkinson’s Disease (PD),...

Bridging the Lessons from Immuno-Oncology to Autoimmunity

We sat down with Alessandra Cesano, M.D., Ph.D., Chief Medical Officer at NanoString Technologies, to discuss her perspective on the relationship between autoimmunity and immuno-oncology research. NanoString (NS): Autoimmunity and cancer are referred to as the opposite sides of the same coin....